Source: Annual Congress 2004 - Lung transplantation: update on clinical and experimental issues



Rating:

Share or cite this content

Citations should be made in the following way:
R. H. Hubner, S. Meffert, U. Mundt, S. Freitag, S. Hirt, N. E. El Mokhtari, U. R. Folsch, B. Bewig (Kiel, Germany). Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J 2004; 24: Suppl. 48, 1146

Member's Comments

No comment yet.

Related content which might interest you: Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Source: Eur Respir J 2008; 32: 670-677 Year: 2008 A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008 Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008 Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011 Validation of a bronchiolitis obliterans rat lung transplant model: the role of MMP-9 Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006 Bronchiectasis as prognostic factor in bronchiolitis obliterans syndrome after lung transplantation Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018 Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 177s Year: 2004 The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis Source: Eur Respir J, 57 (3) 2000344; 10.1183/13993003.00344-2020 Year: 2021 Plasma CRP levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome? Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation Year: 2008 Neutrophil activation and inflammatory response of the respiratory tract of juvenile patients with bronchiolitis obliterans Source: Eur Respir J 2005; 26: Suppl. 49, 29s Year: 2005 Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation Source: Eur Respir J 2014; 43: 221-232 Year: 2004 Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2005; 25: 494-501 Year: 2005 Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Source: Eur Respir J 2005; 25: 221-224 Year: 2005 The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx) Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation Year: 2007 Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004 Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011 IL8 and IL17 are upregulated in BAL fluid of lung transplant patients with bronchiolitis obliterans syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 465s Year: 2004 Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003 Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet? Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55 Year: 2004 Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19 Year: 2004